SCHEMBL5346278

SCHEMBL5346278

Clc1ccc(-c2nc3c(Cl)nc(-c4ccccc4)cn3c2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ ADORA2A P29274 1/20 0.47
▸ AKT1 P31749 11/20 0.46
▸ AKT2 P31751 10/20 0.46
▸ ALDH1A3 P47895 2/20 0.46
▸ ALDH1A2 O94788 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ CSNK1E P49674 1/20 0.40
▸ NR1I2 O75469 1/20 0.40
▸ NR1I3 Q14994 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5348322 0.88 MAPK13 (0.44) KDM4ELMNAGAAL3MBTL1ADORA2A
SCHEMBL5341786 0.86 AKT1 (0.48) KDM4ELMNAGAAL3MBTL1ADORA2A
SCHEMBL5360784 0.80 KDM4E (0.47) KDM4ELMNAGAAL3MBTL1ADORA2A
SCHEMBL5322377 0.77 AKT1 (0.50) KDM4ELMNAGAAL3MBTL1AKT1
SCHEMBL5341130 0.75 ADORA2A (0.39) LMNAADORA2AAKT1AKT2ALDH1A1
SCHEMBL5342418 0.74 DPP4 (0.56) KDM4ELMNAGAAL3MBTL1AKT1
SCHEMBL5318363 0.73 AKT1 (0.62) KDM4ELMNAGAAL3MBTL1AKT1
SCHEMBL5320557 0.73 AKT1 (0.45) AKT1AKT2ALDH1A3NR1I3
SCHEMBL5356111 0.73 AKT1 (0.41) KDM4ELMNAGAAL3MBTL1ADORA2A
SCHEMBL5478849 0.72 AKT1 (0.55) KDM4ELMNAGAAL3MBTL1AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 — — WO claimed
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 — — WO disclosed
Send feedback